Dahari H - Search Results

1

Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations.

Shekhtman L, Cotler SJ, Degasperi E, Anolli MP, Uceda Renteria SC, Sambarino D, Borghi M, Perbellini R, Facchetti F, Ceriotti F, Lampertico P, Dahari H. Shekhtman L, et al. Among authors: dahari h. JHEP Rep. 2023 Nov 15;6(2):100966. doi: 10.1016/j.jhepr.2023.100966. eCollection 2024 Feb. JHEP Rep. 2023. PMID: 38274491 Free PMC article.

2

Silymarin for HCV infection.

Polyak SJ, Oberlies NH, Pécheur EI, Dahari H, Ferenci P, Pawlotsky JM. Polyak SJ, et al. Among authors: dahari h. Antivir Ther. 2013;18(2):141-7. doi: 10.3851/IMP2402. Epub 2012 Sep 25. Antivir Ther. 2013. PMID: 23011959 Free PMC article. Review.

3

The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.

Sabahi A, Marsh KA, Dahari H, Corcoran P, Lamora JM, Yu X, Garry RF, Uprichard SL. Sabahi A, et al. Among authors: dahari h. Virology. 2010 Nov 10;407(1):110-9. doi: 10.1016/j.virol.2010.07.026. Epub 2010 Aug 25. Virology. 2010. PMID: 20800257 Free PMC article.

4

Treatment of hepatitis C with an interferon-based lead-in phase: a perspective from mathematical modelling.

Rong L, Guedj J, Dahari H, Perelson AS. Rong L, et al. Among authors: dahari h. Antivir Ther. 2014;19(5):469-77. doi: 10.3851/IMP2725. Epub 2014 Jan 16. Antivir Ther. 2014. PMID: 24434478 Free PMC article.

5

Hepatitis C virus kinetics in chimeric mice during antiviral therapy.

Dahari H, Perelson AS. Dahari H, et al. Hepatology. 2007 Dec;46(6):2048-9; author reply 2049-50. doi: 10.1002/hep.21798. Hepatology. 2007. PMID: 17935224 No abstract available.

6

Understanding the nature of early HCV RNA blips and the use of mathematical modeling of viral kinetics during IFN-based therapy.

Guedj J, Dahari H, Perelson AS. Guedj J, et al. Among authors: dahari h. Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):E302; author reply E303. doi: 10.1073/pnas.1104149108. Epub 2011 Jun 30. Proc Natl Acad Sci U S A. 2011. PMID: 21719708 Free PMC article. No abstract available.

7

Modeling hepatitis C virus dynamics: liver regeneration and critical drug efficacy.

Dahari H, Lo A, Ribeiro RM, Perelson AS. Dahari H, et al. J Theor Biol. 2007 Jul 21;247(2):371-81. doi: 10.1016/j.jtbi.2007.03.006. Epub 2007 Mar 14. J Theor Biol. 2007. PMID: 17451750 Free PMC article.

8

Hepatitis C virus RNA kinetics: drug efficacy and the rate of HCV-infected cells loss.

Dahari H, Perelson AS. Dahari H, et al. World J Gastroenterol. 2007 Jun 7;13(21):3020-1. doi: 10.3748/wjg.v13.i21.3020. World J Gastroenterol. 2007. PMID: 17589958 Free PMC article. No abstract available.

9

The extrahepatic contribution to HCV plasma viremia.

Dahari H, Forns X, Neumann AU, Perelson AS. Dahari H, et al. J Hepatol. 2006 Oct;45(4):626-7; author reply 627-8. doi: 10.1016/j.jhep.2006.07.004. Epub 2006 Jul 25. J Hepatol. 2006. PMID: 16901578 No abstract available.

10

Antiviral action of ribavirin in chronic hepatitis C.

Pawlotsky JM, Dahari H, Neumann AU, Hezode C, Germanidis G, Lonjon I, Castera L, Dhumeaux D. Pawlotsky JM, et al. Among authors: dahari h. Gastroenterology. 2004 Mar;126(3):703-14. doi: 10.1053/j.gastro.2003.12.002. Gastroenterology. 2004. PMID: 14988824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters